• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

吲哚美辛纳米晶体与聚氧化乙烯/聚氧化丙烯共聚物稳定剂之间的相互作用研究。

Interaction studies between indomethacin nanocrystals and PEO/PPO copolymer stabilizers.

作者信息

Liu Peng, Viitala Tapani, Kartal-Hodzic Alma, Liang Huamin, Laaksonen Timo, Hirvonen Jouni, Peltonen Leena

机构信息

Division of Pharmaceutical Technology, Faculty of Pharmacy, University of Helsinki, P.O. Box 56, 00014, Helsinki, Finland.

出版信息

Pharm Res. 2015 Feb;32(2):628-39. doi: 10.1007/s11095-014-1491-3. Epub 2014 Aug 22.

DOI:10.1007/s11095-014-1491-3
PMID:25145336
Abstract

PURPOSE

The lack of effective screening methods and systemic understanding of interaction mechanisms complicates the stabilizer selection process for nanocrystallization. This study focuses on the efficiency of stabilizers with various molecular compositions and structures to stabilize drug nanocrystals.

METHODS

Five structurally different polymers were chosen as stabilizers for indomethacin nanocrystals. The affinity of polymers onto drug surfaces was measured using surface plasmon resonance (SPR) and contact angle techniques. Nanosuspensions were prepared using the wet-ball milling technique and their physico-chemical properties were thoroughly characterized.

RESULTS

SPR and contact angle measurements correlated very well with each other and showed that the binding efficiency decreased in the order L64 > 17R4 > F68 ≈ T908 ≈ T1107, which is attributed to the reduced PPO/PEO ratio and different polymer structures. The electrostatic interactions between the protonated amine of poloxamines and ionized indomethacin enhanced neither the affinity nor the properties of nanosuspensions, such as particle size and physical stability.

CONCLUSIONS

A good stabilizer should have high binding efficiency, full coverage, and optimal hydrophobic/hydrophilic balance. A high affinity combined with short PEO chains (L64, 17R4) caused poor physical stability of nanosuspensions, whereas moderate binding efficiencies (F68, T908, T1107) with longer PEO chains produced physically stable nanosuspensions.

摘要

目的

缺乏有效的筛选方法以及对相互作用机制的系统理解,使得纳米结晶稳定剂的选择过程变得复杂。本研究聚焦于具有不同分子组成和结构的稳定剂对药物纳米晶体的稳定效率。

方法

选择五种结构不同的聚合物作为吲哚美辛纳米晶体的稳定剂。使用表面等离子体共振(SPR)和接触角技术测量聚合物在药物表面的亲和力。采用湿球磨技术制备纳米混悬液,并对其理化性质进行全面表征。

结果

SPR和接触角测量结果相互之间具有很好的相关性,结果表明结合效率按L64 > 17R4 > F68 ≈ T908 ≈ T1107的顺序降低,这归因于PPO/PEO比例降低和聚合物结构不同。泊洛沙姆质子化胺与离子化吲哚美辛之间的静电相互作用既未增强纳米混悬液的亲和力,也未改善其诸如粒径和物理稳定性等性质。

结论

一种良好的稳定剂应具有高结合效率、完全覆盖以及最佳的疏水/亲水平衡。高亲和力与短PEO链(L64、17R4)相结合会导致纳米混悬液的物理稳定性较差,而具有较长PEO链的中等结合效率(F68、T908、T1107)则产生物理稳定的纳米混悬液。

相似文献

1
Interaction studies between indomethacin nanocrystals and PEO/PPO copolymer stabilizers.吲哚美辛纳米晶体与聚氧化乙烯/聚氧化丙烯共聚物稳定剂之间的相互作用研究。
Pharm Res. 2015 Feb;32(2):628-39. doi: 10.1007/s11095-014-1491-3. Epub 2014 Aug 22.
2
Surface Plasmon Resonance Study of the Binding of PEO-PPO-PEO Triblock Copolymer and PEO Homopolymer to Supported Lipid Bilayers.表面等离子体共振研究聚环氧乙烷-聚环氧丙烷-聚环氧乙烷三嵌段共聚物和聚环氧乙烷均聚物与脂双层的结合。
Langmuir. 2018 Jun 12;34(23):6703-6712. doi: 10.1021/acs.langmuir.8b00873. Epub 2018 Jun 1.
3
A surface plasmon resonance study of albumin adsorption to PEO-PPO-PEO triblock copolymers.白蛋白吸附到聚环氧乙烷-聚环氧丙烷-聚环氧乙烷三嵌段共聚物的表面等离子体共振研究。
J Biomed Mater Res. 1998 Nov;42(2):165-71. doi: 10.1002/(sici)1097-4636(199811)42:2<165::aid-jbm1>3.0.co;2-n.
4
A systematic SPR study of human plasma protein adsorption behavior on the controlled surface packing of self-assembled poly(ethylene oxide) triblock copolymer surfaces.采用 SPR 技术系统研究了在自组装聚(氧化乙烯)三嵌段共聚物表面控制表面组装条件下,人血浆蛋白的吸附行为。
J Biomed Mater Res A. 2010 Apr;93(1):400-8. doi: 10.1002/jbm.a.32558.
5
Adsorption of PEO-PPO-PEO triblock copolymers with end-capped cationic chains of poly(2-dimethylaminoethyl methacrylate).具有封端阳离子链的聚(2-二甲氨基乙基甲基丙烯酸酯)的 PEO-PPO-PEO 三嵌段共聚物的吸附。
Langmuir. 2011 Aug 16;27(16):9769-80. doi: 10.1021/la201596x. Epub 2011 Jul 20.
6
Nano-scale and molecular-level understanding of wet-milled indomethacin/poloxamer 407 nanosuspension with TEM, suspended-state NMR, and Raman measurements.通过 TEM、悬浮态 NMR 和拉曼测量对湿磨吲哚美辛/泊洛沙姆 407 纳米混悬剂进行纳米级和分子级的理解。
Int J Pharm. 2018 Feb 15;537(1-2):30-39. doi: 10.1016/j.ijpharm.2017.12.028. Epub 2017 Dec 12.
7
Enzymatically in situ shell cross-linked micelles composed of 4-arm PPO-PEO and heparin for controlled dual drug delivery.酶法原位壳交联胶束,由 4 臂 PPO-PEO 和肝素组成,用于控制双重药物递送。
J Control Release. 2013 Dec 10;172(2):535-40. doi: 10.1016/j.jconrel.2013.05.003. Epub 2013 May 13.
8
Definition of formulation design space, in vitro bioactivity and in vivo biodistribution for hydrophilic drug loaded PLGA/PEO-PPO-PEO nanoparticles using OFAT experiments.使用单因素实验法对负载亲水性药物的聚乳酸-羟基乙酸共聚物/聚氧乙烯-聚氧丙烯-聚氧乙烯纳米粒的制剂设计空间、体外生物活性及体内生物分布进行定义。
Eur J Pharm Sci. 2013 Apr 11;49(1):65-80. doi: 10.1016/j.ejps.2013.02.004. Epub 2013 Feb 22.
9
Food proteins as novel nanosuspension stabilizers for poorly water-soluble drugs.食物蛋白作为新型纳米混悬剂稳定剂用于难溶性药物。
Int J Pharm. 2013 Jan 30;441(1-2):269-78. doi: 10.1016/j.ijpharm.2012.11.033. Epub 2012 Nov 27.
10
Nanosuspensions of poorly soluble drugs: preparation and development by wet milling.难溶性药物的纳米混悬剂:湿磨法制备与开发。
Int J Pharm. 2011 Jun 15;411(1-2):215-22. doi: 10.1016/j.ijpharm.2011.03.050. Epub 2011 Mar 31.

引用本文的文献

1
PEG-Bottlebrush Stabilizer-Based Worm-like Nanocrystal Micelles with Long-Circulating and Controlled Release for Delivery of a BCR-ABL Inhibitor against Chronic Myeloid Leukemia (CML).基于聚乙二醇 - 瓶刷稳定剂的蠕虫状纳米晶体胶束,具有长循环和控释功能,用于递送针对慢性粒细胞白血病(CML)的BCR-ABL抑制剂。
Pharmaceutics. 2022 Aug 10;14(8):1662. doi: 10.3390/pharmaceutics14081662.
2
Advancement of nanomedicines in chronic inflammatory disorders.纳米医学在慢性炎症性疾病中的进展。
Inflammopharmacology. 2022 Apr;30(2):355-368. doi: 10.1007/s10787-022-00927-x. Epub 2022 Feb 25.
3
The Promising Role of Chitosan-Poloxamer 188 Nanocrystals in Improving Diosmin Dissolution and Therapeutic Efficacy against Ferrous Sulfate-Induced Hepatic Injury in Rats.

本文引用的文献

1
Characterization of polymer adsorption onto drug nanoparticles using depletion measurements and small-angle neutron scattering.使用耗竭测量和小角中子散射对聚合物在药物纳米颗粒上的吸附进行表征。
Mol Pharm. 2013 Nov 4;10(11):4146-58. doi: 10.1021/mp400138e. Epub 2013 Oct 22.
2
Dissolution studies of poorly soluble drug nanosuspensions in non-sink conditions.难溶性药物纳米混悬剂在非饱和条件下的溶出研究。
AAPS PharmSciTech. 2013 Jun;14(2):748-56. doi: 10.1208/s12249-013-9960-2. Epub 2013 Apr 25.
3
The applications of Vitamin E TPGS in drug delivery.
壳聚糖-泊洛沙姆188纳米晶体在改善地奥司明溶解及对硫酸亚铁诱导的大鼠肝损伤的治疗效果方面的潜在作用。
Pharmaceutics. 2021 Dec 5;13(12):2087. doi: 10.3390/pharmaceutics13122087.
4
A Systematic Approach to the Development of Cilostazol Nanosuspension by Liquid Antisolvent Precipitation (LASP) and Its Combination with Ultrasound.液-抗溶剂沉淀法(LASP)制备西洛他唑纳米混悬剂的系统方法及其与超声结合的研究。
Int J Mol Sci. 2021 Nov 17;22(22):12406. doi: 10.3390/ijms222212406.
5
Nanocrystalization: An Emerging Technology to Enhance the Bioavailability of Poorly Soluble Drugs.纳米晶化:一种提高难溶性药物生物利用度的新兴技术。
Pharm Nanotechnol. 2019;7(4):259-278. doi: 10.2174/2211738507666190405182524.
6
Engineering of solidified glyburide nanocrystals for tablet formulation via loading of carriers: downstream processing, characterization, and bioavailability.载药固体化格列吡嗪纳米晶的制剂工程:下游加工、表征和生物利用度。
Int J Nanomedicine. 2019 Mar 13;14:1893-1906. doi: 10.2147/IJN.S194734. eCollection 2019.
7
Parenteral nanosuspensions: a brief review from solubility enhancement to more novel and specific applications.注射用纳米混悬剂:从溶解度提高到更新颖、更具特异性应用的简要综述
Acta Pharm Sin B. 2018 Sep;8(5):733-755. doi: 10.1016/j.apsb.2018.07.011. Epub 2018 Jul 26.
8
Design Space and QbD Approach for Production of Drug Nanocrystals by Wet Media Milling Techniques.湿法制粒技术制备药物纳米晶体的设计空间与质量源于设计方法
Pharmaceutics. 2018 Jul 25;10(3):104. doi: 10.3390/pharmaceutics10030104.
9
Performance Parameters and Characterizations of Nanocrystals: A Brief Review.纳米晶体的性能参数与特性:简要综述。
Pharmaceutics. 2016 Aug 30;8(3):26. doi: 10.3390/pharmaceutics8030026.
10
In Vitro and In Vivo Characterization of Drug Nanoparticles Prepared Using PureNano™ Continuous Crystallizer to Improve the Bioavailability of Poorly Water Soluble Drugs.使用PureNano™连续结晶器制备药物纳米颗粒以提高难溶性药物生物利用度的体外和体内特性研究
Pharm Res. 2016 Sep;33(9):2259-68. doi: 10.1007/s11095-016-1964-7. Epub 2016 Jun 14.
维生素 E TPGS 在药物传递中的应用。
Eur J Pharm Sci. 2013 May 13;49(2):175-86. doi: 10.1016/j.ejps.2013.02.006. Epub 2013 Feb 26.
4
A combined microhydrodynamics-polymer adsorption analysis for elucidation of the roles of stabilizers in wet stirred media milling.联合微流动力学-聚合物吸附分析阐明稳定剂在湿搅拌介质研磨中的作用。
Int J Pharm. 2012 Dec 15;439(1-2):193-206. doi: 10.1016/j.ijpharm.2012.09.040. Epub 2012 Sep 24.
5
Drug nanocrystals in the commercial pharmaceutical development process.药物纳米晶体在商业化药物研发过程中的应用。
Int J Pharm. 2013 Aug 30;453(1):142-56. doi: 10.1016/j.ijpharm.2012.09.034. Epub 2012 Sep 21.
6
Nanosuspensions as advanced printing ink for accurate dosing of poorly soluble drugs in personalized medicines.纳米混悬剂作为先进的印刷油墨,可实现个性化药物中难溶性药物的精确给药。
Int J Pharm. 2011 Nov 25;420(1):93-100. doi: 10.1016/j.ijpharm.2011.08.033. Epub 2011 Aug 22.
7
Nanosuspensions of poorly soluble drugs: preparation and development by wet milling.难溶性药物的纳米混悬剂:湿磨法制备与开发。
Int J Pharm. 2011 Jun 15;411(1-2):215-22. doi: 10.1016/j.ijpharm.2011.03.050. Epub 2011 Mar 31.
8
PEO-PPO block copolymers for passive micellar targeting and overcoming multidrug resistance in cancer therapy.用于被动胶束靶向和克服癌症治疗中多药耐药性的 PEO-PPO 嵌段共聚物。
Curr Drug Targets. 2011 Jul 1;12(8):1112-30. doi: 10.2174/138945011795906615.
9
State of the art of nanocrystals--special features, production, nanotoxicology aspects and intracellular delivery.纳米晶体的最新技术——特殊性质、生产、纳米毒理学方面和细胞内递呈。
Eur J Pharm Biopharm. 2011 May;78(1):1-9. doi: 10.1016/j.ejpb.2011.01.007. Epub 2011 Jan 23.
10
Physical stability of nanosuspensions: investigation of the role of stabilizers on Ostwald ripening.纳米混悬剂的物理稳定性:稳定剂对奥斯特瓦尔德熟化作用影响的研究。
Int J Pharm. 2011 Mar 15;406(1-2):145-52. doi: 10.1016/j.ijpharm.2010.12.027. Epub 2010 Dec 24.